23andMe Holding


23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generatesmaximum revenue from the Consumer and Research Services segment.

2006 (17 years)
Investor RelationsSEC
299 million (2023)

Want to see more? Sign up!